← All companies
NEKTAR THERAPEUTICS
NKTR - CIK 0000906709
Market cap$1.92 B
Rank#2127
SEC filings1,949
The table below shows NEKTAR THERAPEUTICS's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $149.58M | $41.03M | $42.99M | $38.89M | $30.11M | $27.94M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | $0.00 | $1.20M |
| Inventory | - | - | - | - | $0.00 | $14.46M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.